Yuuri Hashimoto

4.0k citations
91 papers · 2.3k indexed · 1 hit paper · h-index 24

Yuuri Hashimoto

91 papers receiving 2.3k citations

Hit Papers

Osteopontin mediates glioblastoma-associated macrophage i...287201820262020202350100150200250

Peers

Yuuri Hashimoto
Comparison fields: 5 of 100
  • Biotechnology 455
  • Oncology 776
  • Immunology 589
  • Cancer Research 396
  • Genetics 251
Replace Syed R. Husain with:
Syed R. Husain United States
Hideo Takeshima Japan
Sandrine Valsesia‐Wittmann France
Toru Nishi Japan
Hidefumi Hiramatsu Japan
Gregory E. Plautz United States
Joan M. Robbins United States
Yoko Oei United States
Andrew Wilber United States
Perry D. Nisen United States
Yuuri Hashimoto relative to Syed R. Husain United States Syed R. Husain's profile →
Citations per field
00.5×1.5×2.3×
Syed R. Husain · 1×
Citations per year

Countries citing papers authored by Yuuri Hashimoto

Since Specialization
Citations

This map shows the geographic impact of Yuuri Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuuri Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuuri Hashimoto more than expected).

Fields of papers citing papers by Yuuri Hashimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuuri Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuuri Hashimoto. The network helps show where Yuuri Hashimoto may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yuuri Hashimoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuuri Hashimoto Line = papers co-authored together Yuuri Hashimoto links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202041
2 201641
3 201518
4 201572
5 201422
6 201353
7 201364
8 201222
9 20121
10 201143
11 201061
12 201018
13 200940
14 200916
15 200857
16 200128
17 199914
18
[A fluoroscopic analysis of the catheters abnormally placed in the epidural space].
19961
19 199520
20 199393

About Yuuri Hashimoto

Yuuri Hashimoto is a scholar working on Biotechnology, Anesthesiology and Pain Medicine and Oncology, having authored 91 papers that have together received 2.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (23 papers), Cancer Research and Treatments (19 papers), RNA Interference and Gene Delivery (11 papers), CAR-T cell therapy research (8 papers), Anesthesia and Sedative Agents (7 papers), Cancer Cells and Metastasis (7 papers), Glioma Diagnosis and Treatment (5 papers) and Asthma and respiratory diseases (5 papers). The work is most often cited by research in Biotechnology (455 citations), Oncology (776 citations) and Immunology (589 citations). Yuuri Hashimoto has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Toshiyoshi Fujiwara, Shunsuke Kagawa, Yasuo Urata, Futoshi Uno, Hiroshi Tazawa, Amy B. Heimberger, Yuichi Watanabe, Shouhao Zhou, Shinji Kuroda and Gregory N. Fuller.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026